Cargando…
Preoperative and postoperative prognostic factors of patients with stage II/III lower rectal cancer without neoadjuvant therapy in the clinical trial (JCOG0212)
BACKGROUND: The JCOG0212 trial was a randomized controlled trial comparing mesorectal excision alone to mesorectal excision with lateral lymph node dissection for stage II/III lower rectal cancer patients without clinical lateral lymph node enlargement. This study aimed to identify clinicopathologic...
Autores principales: | Ohue, Masayuki, Fujita, Shin, Mizusawa, Junki, Kanemitsu, Yukihide, Hamaguchi, Tetsuya, Tsukamoto, Shunsuke, Noura, Shingo, Yasui, Masayoshi, Itoh, Masaaki, Shiomi, Akio, Komori, Koji, Watanabe, Jun, Akazai, Yoshihiro, Shiozawa, Manabu, Yamaguchi, Takashi, Bandou, Hiroyuki, Katsumata, Kenji, Moriya, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9055856/ https://www.ncbi.nlm.nih.gov/pubmed/34865105 http://dx.doi.org/10.1093/jjco/hyab183 |
Ejemplares similares
-
Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212
por: Katsumata, Kenji, et al.
Publicado: (2021) -
A randomized controlled trial comparing perioperative vs. postoperative mFOLFOX6 for lower rectal cancer with suspected lateral pelvic lymph node metastasis (JCOG1310): a phase II/III randomized controlled trial
por: Ohue, Masayuki, et al.
Publicado: (2022) -
A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study)
por: Ohue, Masayuki, et al.
Publicado: (2017) -
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
por: Kanemitsu, Yukihide, et al.
Publicado: (2021) -
A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)
por: Moritani, Konosuke, et al.
Publicado: (2019)